


Nexus Dynamix
Biotechnology Research • Vilnius, Vilnius County, Lithuania • 1-10 Employees
Company overview
| Headquarters | Vilnius, Vilnius County, Lithuania |
| Website | |
| NAICS | 541714 |
| Keywords | Biotechnology, Space, Longevity |
| Employees | 1-10 |
| Socials |
Key Contact at Nexus Dynamix
Felipe Rubio
Co-founder & COO | Vision & Execution
Nexus Dynamix Email Formats
Nexus Dynamix uses 1 email format. The most common is {first name} (e.g., john@nexusdynamix.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name} | john@nexusdynamix.com | 100% |
About Nexus Dynamix
At Nexus Dynamix, we’re not just pushing boundaries—we’re breaking them. We’re pioneering the use of microgravity simulations to revolutionize both biotech and defense industries. By bringing the power of zero gravity down to Earth, we’re transforming how we approach wellness, drug development, and even cancer therapy. Our journey started with a bold question: What if we could use space-like conditions to unlock new possibilities in human health? That question launched us into the field of longevity, using microgravity to slow down cellular aging and explore how we can enhance wellness and extend healthy lifespans. But we didn’t stop there. As we refined our technology, we uncovered a far greater potential: microgravity’s ability to revolutionize drug development. Our simulations allow cells to grow in their natural 3D form, enabling faster, more accurate testing of new therapies. This cutting-edge approach accelerates drug discovery, helping us develop groundbreaking treatments faster than ever before. And our most exciting breakthrough? Cancer therapy. By applying microgravity, we’re developing non-invasive treatments that could reshape oncology, providing new hope for those fighting this devastating disease. What makes us unique is our dual-use technology. Our platform seamlessly serves both the biotech and defense sectors—allowing us to innovate at the intersection of life sciences and national security. From drug development to defense testing, Nexus Dynamix is pushing the limits of what’s possible. We’re committed to driving progress, transforming the future of health, and creating a world where the impossible becomes achievable. Whether it’s extending lifespans, curing diseases, or enhancing defense capabilities, Nexus Dynamix is bringing the future closer, one breakthrough at a time.
Nexus Dynamix revenue & valuation
| Annual revenue | $171,110 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $547,552 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Nexus Dynamix has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Nexus Dynamix has never raised funding before.
Frequently asked questions
4.8
40,000 users



